Fluid-guided heart failure management using the Bodyport Cardiac Scale
Official title: Fluid Guided Heart Failure Treatment
Run by Bodyport Inc. · NCT07205120 · Data updated 2026-11-12
This pilot will test whether a program using the Bodyport Cardiac Scale and a Congestion Index can help guide care for adults with acute or chronic heart failure followed at the Cleveland Clinic.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Bodyport Inc. Industry-sponsored |
| Locations | 1 site (Cleveland, Ohio) |
| Status | Recruiting |
| Started | October 8, 2025 |
| Main results expected | April 2027 |
| Study ends | April 2027 |
| Registry record updated | October 20, 2026 |
| Trial ID | NCT07205120 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults age 21 or older hospitalized for acute decompensated heart failure or with chronic heart failure who are followed by a Cleveland Clinic cardiologist, can stand on two bare feet, and can read and speak English.
✕Probably not a fit
Patients unlikely to benefit include those with NYHA class IV symptoms, planned transplant or VAD, severe renal failure or dialysis dependence, regular IV heart-failure therapy, pregnancy, inability to stand unassisted, or weight over 375 lbs.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
FIGHT-HF is a non-randomized, open-label pilot enrolling 50 adults with acute or chronic heart failure who are followed by a Cleveland Clinic cardiologist. Participants will use the Bodyport Cardiac Scale and a composite Congestion Index to generate alerts that are processed through an Alert Response Guide (ARG). The study will integrate the scale and ARG into existing clinical workflows to see how the data perform in routine care and to refine management protocols. Results will inform potential future randomized trials of Congestion Index-guided heart failure management.
Why it matters
Potential benefit: If successful, this approach could help detect fluid congestion earlier and guide timely treatment changes to reduce symptoms and hospital visits.
How similar studies have gone: Implanted hemodynamic monitors and some remote monitoring programs have shown clinical benefit, but noninvasive scale-based congestion algorithms like this are newer and have limited prior outcome data.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Hospitalized for acute decompensated heart failure * Age 21 years or older * Able to speak and read English Exclusion Criteria: * New York Heart Association functional class IV symptoms * Received or are scheduled to receive a heart transplant or ventricular assist - device in the next 12 months * Have a glomerular filtration rate of less than 25 mL/min while nonresponsive to diuretic therapy or on chronic renal dialysis * Have a history of regularly scheduled intravenous HF therapy (e.g., inotropes or diuretics) * Have a life expectancy of less than 12 months * Are pregnant or plan to become pregnant during the next 12 months * Weigh greater than 375 lbs * Unable to stand on two bare feet without assistance
Where it's running
-
The Cleveland Clinic
Cleveland, Ohio, United States Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Comparing Aortix Device to Diuretics for Acute Heart Failure
This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.
-
Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS
Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
NT-proBNP–guided heart failure screening for people 65+ in rural China
This study tests whether using NT-proBNP blood tests to guide heart failure screening in adults 65 and older in rural China can find unrecognized heart problems more effectively than symptom-based screening.
-
Voice-based detection of heart failure deterioration using Noah Labs Vox
This study tests whether a voice-analysis app can flag worsening heart failure in adults by comparing its alerts to standard weight-based monitoring.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.